Atomoxetine hydrochloride (HCI) ATOXETIME 18  is a medication primarily used in the treatment of attention-deficit/hyperactivity disorder (ADHD) in children, adolescents, and adults. ATOXETIME 18  is sold under the brand name Strattera. Here are some key points about ATOXETIME 18 : Indications: ATOXETIME 18  is indicated for the treatment of ADHD, a neurodevelopmental disorder characterized by symptoms such as hyperactivity, impulsivity, and difficulty sustaining attention. ATOXETIME 18  is used as part of a comprehensive treatment plan that includes psychological, educational, and social measures. Mechanism of action: ATOXETIME 18  is a selective norepinephrine reuptake inhibitor (SNRI). It works by increasing the levels of norepinephrine, a neurotransmitter, in the brain. The exact mechanism by which atomoxetine improves symptoms of ADHD is not fully understood. Effectiveness: ATOXETIME 18  has been shown to reduce ADHD symptoms, such as inattention, hyperactivity, and impulsivity, in clinical studies. It may take several weeks to notice the full effects of the medication, and individual responses can vary. For further information please contact: info@sterispharma.com order now: - https://www.sterisonline.com/product/atoxetime-18-134295